Skip to main content

Table 1 Summary of the main characteristics of included studies

From: Intermittent hypoxia reduces infarct size in rats with acute myocardial infarction: a systematic review and meta-analysis

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

Yuan 2017 [4]

SD

M

330–350 g

5000 m altitude

6 h/day

28 days

G

30

120

sodium pentobarbital

IR/VR

Means±SD

4

12.8

2.0

4

38.4

5

Li 2016 [24]

SD

M

220 ±? g

5000 m altitude

6 h/day

28 days

G

30

120

sodium pentobarbital

IR/VR

Means±SD

6

27.3

5.9

6

48.3

7.5

Kasparova 2015 [3]

W

M

300–380 g

Normobaric FiO2 10%

8 h/day

21 days

LAD

20

180

Sodium pentobarbital

IR/AAR

Means±SE

10

46.4

4.2

10

62.7

2.7

Meng 2014 [25]

W

M

150–180 g

5000 m altitude

6 h/day

42 days

LAD

30

240

25% ethylurethanm solution

IR/AAR

Means±SE

7

12.5

1.6

7

30.9

6.8

Ma 2014 [26]

SD

M

neonate

3000 m altitude

5 h/day

42 days

G

30

120

sodium pentobarbital

IR/VR

Means±SE

6

26.7

0.4

6

48.6

2.2

Gao 2014 [27]

SD

M

100–130 g

5000 m altitude

4 h/day

28 days

G

30

120

sodium pentobarbital

IR/AAR

Means±SE

5

22.58

3

5

35.9

4.1

Manukhina 2013 [28]

W

M

250–280 g

Normobaric FiO2 9.5–10%

4 min/cycle

5–8 cycles/day 20 days

LAD

30

120

urethane

IR/AAR

Means±SE

10

17.5

2.6

9

30.6

5.1

Ramond 2013a [16]

W

M

250–350 g

Normobaric FiO2 5%

40s/min 8 h/d

14 days

G

30

120

sodium pentobarbital

IR/VR

Means±SE

7

36.0

2.8

7

21.8

3.1

Ramond 2013b [16]

W

M

250–350 g

Normobaric FiO2 5%

40s/min 8 h/d

14 days

G

30

120

sodium pentobarbital

IR/VR

Means±SE

8

40.3

3.5

8

29.4

3.7

Milano 2011 [17]

SD

M

251 ± 2 g

Normobaric FiO2 10%

23 h/day

15 days

LAD

30

180

sodium pentobarbital

IR/AAR

Means±SE

7

68.5

2.4

7

46.5

4.4

Wang 2011 [29]

SD

M

100–120 g

5000 m altitude

4 h/day

28 days

G

30

120

pentobarbital sodium

IR/AAR

Means±SE

5

20.5

5.3

5

42.1

3.8

Belaidi 2008 [30]

W

M

330–350 g

Normobaric FiO2 10%

4 h/day

1 day

G

30

120

pentobarbital sodium

IR/VR

Means±SE

8

15.9

5.6

8

33.8

5

Yeung 2007a [31]

SD

M

290–320 g

Normobaric FiO2 10%

6 h/day

3 days

LCA

30

120

decapitated

IR/AAR

Means±SE

6

32.7

1.2

6

35.1

1.8

Yeung 2007b [31]

SD

M

290–320 g

Normobaric FiO2 10%

6 h/day

7 days

LCA

30

120

decapitated

IR/AAR

Means±SE

6

26.5

0.7

6

34.8

1.1

Yeung 2007c [31]

SD

M

290–320 g

Normobaric FiO2 10%

6 h/day

14 days

LCA

30

120

decapitated

IR/AAR

Means±SE

6

31.71

1.0

6

37.7

2.0

Ravingerová 2007 [32]

W

M

250–280 g

7000 m altitude

8 h/day

5 days/week 25–30 days

LAD

20

180

sodium pentobarbiton

IR/AAR

Means±SE

8

51.8

4.4

8

64.9

5.1

Kolár 2007 [33]

W

M

250–280 g

7000 m altitude

8 h/day

24–30 days

LAD

20

180

sodium pentobarbital

IR/AAR

Means±SE

8

27.7

4.9

8

56.7

4.5

Béguin 2007 [34]

W

M

330–380 g

5000 m altitude

4 h/d

1 day

G

30

120

sodium pentobarbital

IR/VR

Means±SE

8

22.2

2.4

8

33.8

2.6

Zhu 2006 [35]

SD

M

100–130 g

5000 m altitude

6 h/day

42 days

G

30

120

sodium pentobarbital

IR/VR (LV area)

Means±SE

7

24

1.9

7

42.1

2.1

Kolár 2005 [36]

W

M

5–6 weeks

7000 m altitude

8 h/day

35–42 days

LAD

20

180

sodium pentobarbiton

IR/AAR

Means±SE

7

43.2

3.3

7

59.2

4.4

Béguin 2005 [37]

W

M

330–380 g

Normobaric FiO2 10%

40s/min 4 h/d

1d

G

30

120

sodium pentobarbiton

IR/VR (LV area)

Means±SE

11

21.8

3.1

9

33.5

2.5

Joyeux-Faure 2005 [38]

W

M

220–240 g

Normobaric FiO2 5%

40s/min 8 h/d

35 days

G

30

120

sodium pentobarbiton

IR/VR

Means±SE

9

46.9

3.6

9

26.1

2.8

Neckár 2005a [39]

W

M

250–280 g

7000 m altitude

8 h/day

24–32 days

LAD

20

180

sodium pentobarbital

IR/AAR

Means±SE

9

41.2

3.9

9

58.2

2.2

Neckár 2005b [39]

W

M

250–280 g

7000 m altitude

8 h/day

24–32 days

LAD

20

180

sodium pentobarbital

IR/AAR

Means±SE

9

33.9

3.8

9

58.9

3.7

Neckár 2004 [40]

W

M

250–280 g

7000 m altitude

8 h/day

5 days a week 35 days

LAD

30

240

sodium pentobarbiton

IR/AAR

Means±SE

11

48

2.2

15

69.2

1.7

Neckár 2002a [41]

W

M

250–280 g

5000 m altitude

8 h/day

5 days a week 24–32 days

G

20

240

sodium pentobarbiton

IR/AAR

Means±SE

16

52.7

2.5

10

62.2

2

Neckár 2002b [41]

W

M

250–280 g

5000 m altitude

8 h/day

5 days a week 24–32 days

G

20

240

sodium pentobarbiton

IR/AAR

Means±SE

9

51.5

2.2

9

60.2

2.6

Neckár 2002c [42]

W

M

250–280 g

7000 m altitude

8 h/day

5 days a week 24–30 days

LAD

30

240

sodium pentobarbiton

IR/AAR

Means±SE

19

50.2

1.9

10

66.6

2.3

  1. Different letters refer to different studies and experimental groups within each included study. SD, Sprague-Dawley rats; W, Wistar rats; M, male; 7000 m altitude (around PB 308 mmHg, PO2 65 mmHg, FiO2 9.75%), 5000 m altitude (around PB 404 mmHg, PO2 85 mmHg, FiO2 12.95%), 3000 m altitude (around PB 525 mmHg, PO2 110 mmHg, FiO2 14.4%), sea-level (around PB 760 mmHg, PO2 159 mmHg, FiO2 20.95%); G, global ischemia; LAD, left anterior descending; LCA, left coronary artery; IS, infarct size; VS, ventricle size; AAR, area at risk; SEM, standard error of the mean; STD, standard deviation of the mean. The main characteristics included (1) study, year, reference; (2) species; (3) sex; (4) age or weight; (5) oxygen concentration (Fi O2); (6) daily hypoxic exposure (hour); (7) total stimulus duration (day); (8) ligation of coronary artery; (9) duration of index ischemia duration (min); (10) reperfusion duration (h); (11) induction anesthetic; (12) measurement of IS; (13) measurement of variance; (14) control group sample size; (15) control group mean infarct size; (16) control group variance; (17) conditioning group sample size; (18) conditioning group mean infarct size; (19) conditioning group variance